Accelerate Diagnostics, Inc. IPO Advisory
Share this IPO Profile:
Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
Accelerate Diagnostics, Inc. | AXDX - |
Last trade $3.42 |
$2.00 |
$0.00 | 17.5 million | 8/19/2022 |
William Blair & Co. |
Co-Manager(s): |
|
Filing(s): |
For IPO Boutique's "scale of 1 to 5" BUY rating on Accelerate Diagnostics, Inc., and our comprehensive analysis, click "Buy Market Research".
Accelerate Diagnostics, Inc. Quote & Chart - Click for current quote -
AXDX
About Accelerate Diagnostics, Inc. (adapted from Accelerate Diagnostics, Inc. prospectus):
Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antimicrobial resistance and sepsis. The Accelerate Pheno® system and Accelerate Arc™ system are designed to reduce the time clinicians must wait to determine the most optimal antibiotic therapy for bacteremic patients.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "AXDX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
© 2005 - 2024 IPO Boutique. All Rights Reserved